JAC Advance Access originally published online on November 16, 2004
Journal of Antimicrobial Chemotherapy 2005 55(1):102-105; doi:10.1093/jac/dkh489
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
JAC vol.55 no.1 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved
Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay
1 Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N. D3-100, Seattle, WA 98109; 2 Department of Medicine, University of Washington, Seattle, WA, USA
* Corresponding author. Tel: +1-206-667-1806; Fax: +1-206-667-4411; Email: abalajee{at}fhcrc.org
Objectives: We have investigated the use of a viability dye, chloromethylfluorescein di-acetate (CMFDA), for antifungal susceptibility testing in a fluorescence microplate (FM) assay format.
Methods: For this FM assay, conidia were incubated in increasing concentrations of antifungal drug for 16 h and stained with CMFDA. Fluorescence, measured as mean fluorescence units (MFU) in a fluorescence microplate reader, was graphed relative to that of a drug-free control, and the MIC was defined as the lowest concentration of the drug that resulted in complete reduction (100%) in MFU for amphotericin B, or 90% reduction in MFU for itraconazole and voriconazole. Susceptibilities of 10 clinical isolates of Aspergillus fumigatus, Aspergillus terreus and Aspergillus niger to amphotericin B, itraconazole and voriconazole were tested in a blinded fashion using the FM and the NCCLS methods.
Results and conclusions: Reproducibility of the FM assay was excellent, and results correlated with those of the NCCLS microdilution method. The FM assay appears to be a rapid, objective method for testing fungal susceptibilities to itraconazole, voriconazole and amphotericin B.
Keywords: MICS , susceptibility testing , fluorescent dyes , Aspergillus spp.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. A. Zarember, A. R. Cruz, C.-Y. Huang, and J. I. Gallin Antifungal Activities of Natural and Synthetic Iron Chelators Alone and in Combination with Azole and Polyene Antibiotics against Aspergillus fumigatus Antimicrob. Agents Chemother., June 1, 2009; 53(6): 2654 - 2656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Araujo, I. Coutinho, and A. Espinel-Ingroff Rapid method for testing the susceptibility of Aspergillus fumigatus to amphotericin B, itraconazole, voriconazole and posaconazole by assessment of oxygen consumption J. Antimicrob. Chemother., December 1, 2008; 62(6): 1277 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Zarember, J. A. Sugui, Y. C. Chang, K. J. Kwon-Chung, and J. I. Gallin Human Polymorphonuclear Leukocytes Inhibit Aspergillus fumigatus Conidial Growth by Lactoferrin-Mediated Iron Depletion J. Immunol., May 15, 2007; 178(10): 6367 - 6373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Antachopoulos, J. Meletiadis, T. Sein, E. Roilides, and T. J. Walsh Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species J. Antimicrob. Chemother., February 1, 2007; 59(2): 230 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Antachopoulos, J. Meletiadis, E. Roilides, T. Sein, and T. J. Walsh Rapid Susceptibility Testing of Medically Important Zygomycetes by XTT Assay J. Clin. Microbiol., February 1, 2006; 44(2): 553 - 560. [Abstract] [Full Text] [PDF]
|
|